GlobeNewswire Inc | Jan 27, 2021 12:10PM EST

January 27, 2021

MONTRAL, Jan. 27, 2021 (GLOBE NEWSWIRE) -- Elixxer Ltd.(TSX-V: ELXR) (OTC-QB: ELIXF) (FRA: 2LQA) (Elixxer or the company) is pleased to share the latest achievements of its largest holding Little Green Pharma Ltd. (LGP). LGP has achieved the following major milestone validating our investment:

The French Agency for the Safety of Medicines and Health Products (ANSM) has selected Little Green Pharma as 1 of 4 companies that will supply Frances medical cannabis pilot program. Under the program, participants will be provided with free products to patients that enol in the trial. LGP will be a both a main & substitute supplier for CBD sublingual oils.

CurrentlyElixxerholds 27.4M shares of LGP and as of January 27, 2021 the closing price was$0.64per share on the ASX, click link:LGP Share Price

Elixxerwill update the investors via press release on further developments from its holdings.

AboutElixxerLtd. (www.Elixxer.com)

Elixxeris a Canadian public company listed on theTSX Venture Exchange(TSX-V: ELXR) and the US OTC-QB exchange (OTCQB: ELIXF).

Through its partners,Elixxerpresently has significant interests inAustralia,Jamaica,Switzerland,ItalyandCanada.

For further information please contact:Info@elixxer.com

Caution Regarding Press Releases

Neither theTSX Venture Exchangenor its Regulation Service Provider (as that term is defined in the policies of theTSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Notice Regarding Forward Looking Statements

This press release may contain forward-looking statements with respect toElixxerand its operations, strategy, investments, financial performance and condition. These statements can generally be identified by use of forward-looking words such as may, will, expect, estimate, anticipate, intends, believe or continue or the negative thereof or similar variations. The actual results and performance ofElixxercould differ materially from those expressed or implied by such statements. Such statements are qualified in their entirety by the inherent risks and uncertainties surrounding future expectations. Some important factors that could cause actual results to differ materially from expectations include, among other things, general economic and market factors, competition, government regulation and the factors described under Risk Factors and Risk Management in Elixxers most recent Managements Discussion and Analysis filed on SEDAR (www.sedar.com). The cautionary statements qualify all forward-looking statements attributable toElixxerand persons acting on its behalf. Unless otherwise stated, all forward-looking statements speak only as of the date of this press release, andElixxerhas no obligation to update such statements, except to the extent required by applicable securities laws.